Literature DB >> 21272576

Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice.

Harry A Quigley1, Frances E Cone, Scott E Gelman, Zhiyong Yang, Janice L Son, Ericka N Oglesby, Mary E Pease, Donald J Zack.   

Abstract

To determine if the absence of c-Jun N-terminal kinase 3 (JNK3) in the mouse retina would reduce retinal ganglion cell (RGC) loss in mice with experimental glaucoma. C57BL/6 mice underwent experimental intraocular pressure (IOP) elevation with a bead/viscoelastic injection into one eye. One-half of the mice were Jnk3 homozygous knockouts (KO) and were compared to wild type (WT) mice. IOP was measured under anesthesia with the TonoLab, axial length was measured post-mortem with calipers after inflation to 15mmHg, and RGC layer counts were performed on retinal whole mount images stained with DAPI, imaged by confocal microscopy, and counted by masked observers in an image analysis system. Axon counts were performed in optic nerve cross-sections by semi-automated image analysis. Both WT and Jnk3(-/-) mice had mean elevations of IOP of more than 50% after bead injection. Both groups underwent the expected axial globe elongation due to chronic IOP elevation. The absence of JNK3 in KO retina was demonstrated by Western blots. RGC layer neuron counts showed modest loss in both WT and Jnk3(-/-) animals; local differences by retinal eccentricity were detected, in each case indicating greater loss in KO animals than in WT. The baseline number of RGC layer cells in KO animals was 10% higher than in WT, but the number of optic nerve axons was identical in KO and WT controls. A slightly greater loss of RGC in Jnk3(-/-) mice compared to controls was detected in experimental mouse glaucoma by RGC layer counting and there was no protective effect shown in axon counts. Counts of RGC layer cells and optic nerve axons indicate that Jnk3(-/-) mice have an increased number of amacrine cells compared to WT controls.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21272576      PMCID: PMC3060951          DOI: 10.1016/j.exer.2011.01.006

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  36 in total

1.  Switching mature retinal ganglion cells to a robust growth state in vivo: gene expression and synergy with RhoA inactivation.

Authors:  Dietmar Fischer; Victoria Petkova; Solon Thanos; Larry I Benowitz
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

2.  Calibration of the TonoLab tonometer in mice with spontaneous or experimental glaucoma.

Authors:  Mary E Pease; Frances E Cone; Scott Gelman; Janice L Son; Harry A Quigley
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-22       Impact factor: 4.799

3.  Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene.

Authors:  D D Yang; C Y Kuan; A J Whitmarsh; M Rincón; T S Zheng; R J Davis; P Rakic; R A Flavell
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

4.  Direct inhibition of c-Jun N-terminal kinase in sympathetic neurones prevents c-jun promoter activation and NGF withdrawal-induced death.

Authors:  A Eilers; J Whitfield; B Shah; C Spadoni; H Desmond; J Ham
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

5.  Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes.

Authors:  G Tezel; R Hernandez; M B Wax
Journal:  Arch Ophthalmol       Date:  2000-04

6.  Light damage induced changes in mouse retinal gene expression.

Authors:  Lin Chen; Wayne Wu; Tzvete Dentchev; Yong Zeng; Jianhua Wang; Irena Tsui; John W Tobias; Jean Bennett; Donald Baldwin; Joshua L Dunaief
Journal:  Exp Eye Res       Date:  2004-08       Impact factor: 3.467

7.  Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells.

Authors:  Osamu Sekine; Yoshihiko Nishio; Katsuya Egawa; Takaaki Nakamura; Hiroshi Maegawa; Atsunori Kashiwagi
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

8.  The c-Jun N-terminal protein kinase signaling pathway mediates Bax activation and subsequent neuronal apoptosis through interaction with Bim after transient focal cerebral ischemia.

Authors:  Shuzo Okuno; Atsushi Saito; Takeshi Hayashi; Pak H Chan
Journal:  J Neurosci       Date:  2004-09-08       Impact factor: 6.167

9.  Immunohistochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma.

Authors:  Gülgün Tezel; Balwantray C Chauhan; Raymond P LeBlanc; Martin B Wax
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-07       Impact factor: 4.799

10.  Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury.

Authors:  T Herdegen; F X Claret; T Kallunki; A Martin-Villalba; C Winter; T Hunter; M Karin
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

View more
  20 in total

1.  Quantitative measurement of retinal ganglion cell populations via histology-based random forest classification.

Authors:  Adam Hedberg-Buenz; Mark A Christopher; Carly J Lewis; Kimberly A Fernandes; Laura M Dutca; Kai Wang; Todd E Scheetz; Michael D Abràmoff; Richard T Libby; Mona K Garvin; Michael G Anderson
Journal:  Exp Eye Res       Date:  2015-10-22       Impact factor: 3.467

2.  Effect of the M1 Muscarinic Acetylcholine Receptor on Retinal Neuron Number Studied with Gene-Targeted Mice.

Authors:  Panagiotis Laspas; Jan J Sniatecki; Christoph Brochhausen; Andreas Steege; Evgeny Goloborodko; Marcin L Kordasz; Franz H Grus; Norbert Pfeiffer; Adrian Gericke
Journal:  J Mol Neurosci       Date:  2015-02-28       Impact factor: 3.444

Review 3.  Intrinsic axonal degeneration pathways are critical for glaucomatous damage.

Authors:  Gareth R Howell; Ileana Soto; Richard T Libby; Simon W M John
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

4.  Transplantation of iPSC-derived TM cells rescues glaucoma phenotypes in vivo.

Authors:  Wei Zhu; Oliver W Gramlich; Lauren Laboissonniere; Ankur Jain; Val C Sheffield; Jeffrey M Trimarchi; Budd A Tucker; Markus H Kuehn
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

5.  Activation of TLR3 promotes the degeneration of retinal ganglion cells by upregulating the protein levels of JNK3.

Authors:  Shravan K Chintala; Nahrain Putris; Mason Geno
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-06       Impact factor: 4.799

6.  Semi-automated, quantitative analysis of retinal ganglion cell morphology in mice selectively expressing yellow fluorescent protein.

Authors:  Ericka Oglesby; Harry A Quigley; Donald J Zack; Frances E Cone; Matthew R Steinhart; Jing Tian; Mary E Pease; Giedrius Kalesnykas
Journal:  Exp Eye Res       Date:  2011-12-22       Impact factor: 3.467

7.  Unraveling the neuroprotective mechanisms of PrP (C) in excitotoxicity.

Authors:  Franc Llorens; José Antonio Del Río
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

Review 8.  Targets of Neuroprotection in Glaucoma.

Authors:  Shaoqing He; Dorota L Stankowska; Dorette Z Ellis; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  J Ocul Pharmacol Ther       Date:  2017-08-18       Impact factor: 2.671

Review 9.  Inducible rodent models of glaucoma.

Authors:  Iok-Hou Pang; Abbot F Clark
Journal:  Prog Retin Eye Res       Date:  2019-09-23       Impact factor: 21.198

10.  KLF9 and JNK3 Interact to Suppress Axon Regeneration in the Adult CNS.

Authors:  Akintomide Apara; Joana Galvao; Yan Wang; Murray Blackmore; Allison Trillo; Keiichiro Iwao; Dale P Brown; Kimberly A Fernandes; Abigail Huang; Tu Nguyen; Masoumeh Ashouri; Xiong Zhang; Peter X Shaw; Noelia J Kunzevitzky; Darcie L Moore; Richard T Libby; Jeffrey L Goldberg
Journal:  J Neurosci       Date:  2017-09-04       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.